Garadacimab - Hereditary angiodema

You are here : Home > Formulary Search > Garadacimab - Hereditary angiodema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Subconjunctival injection

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

NHSE

Restrictions / Comments :

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Garadacimab

Indication :

Hereditary angiodema

Group Name :

Keywords :

Brand Names Include :

Andembry

Important Information :

Prevention of recurrent attacks in people 12 years and over. Immunology specialist only

Latest Additions Date From :

18 Dec 2025

Latest Additions Date To :

18 Jan 2026

Guidelines :

Supporting Documents :

Committee Recommendations (1)

05 Dec 25 - RSFT DTC

Approved for immunology specialist only at RSFT DTC 5th Dec 2025

Other Indications

Below are listed other indications that Garadacimab is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hereditary angiodema.